Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Minerva Neuroscie (NERV)

Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Minerva Neurosciences: Q1 Earnings Snapshot AP - Wed May 1, 6:43AM CDT

Minerva Neurosciences: Q1 Earnings Snapshot

NERV : 3.08 (-2.61%)
Minerva Neurosciences: Q4 Earnings Snapshot AP - Thu Feb 22, 6:41AM CST

Minerva Neurosciences: Q4 Earnings Snapshot

NERV : 3.08 (-2.61%)
Minerva Neurosciences: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Minerva Neurosciences: Q3 Earnings Snapshot

NERV : 3.08 (-2.61%)
Minerva Neurosciences: Q2 Earnings Snapshot AP - Tue Aug 1, 2023

Minerva Neurosciences: Q2 Earnings Snapshot

NERV : 3.08 (-2.61%)
People and teaching - Two Colleagues Talking About Markets
Bump up Your Long Term Portfolio Performance With Low Beta Stocks Barchart - Wed May 17, 2023

In this article, discover how low beta stocks can shimmer in your portfolio!

MSFT : 459.28 (+0.56%)
NERV : 3.08 (-2.61%)
STIX : 0.3000 (-19.14%)
SERA : 5.59 (-7.45%)
TCRX : 5.73 (-3.37%)
NVCT : 6.51 (+5.34%)
Minerva Neurosciences: Q1 Earnings Snapshot AP - Mon May 15, 2023

Minerva Neurosciences: Q1 Earnings Snapshot

NERV : 3.08 (-2.61%)
Minerva Neurosciences: Q4 Earnings Snapshot AP - Wed Mar 8, 2023

Minerva Neurosciences: Q4 Earnings Snapshot

NERV : 3.08 (-2.61%)
Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates FinancialNewsMedia - Mon Nov 14, 2022

EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END

CYBN.NE : 0.3550 (-4.05%)
MRVL.VN : 0.120 (unch)
SAGE : 10.82 (-1.90%)
NERV : 3.08 (-2.61%)
ATAI : 1.3000 (-3.70%)
CYBN : 0.2649 (-0.04%)
Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates PR Newswire - Mon Nov 14, 2022

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Anti-anxiety drugs are medications that are used to treat anxiety disorders that are mainly used to...

MRVL.VN : 0.120 (unch)
SAGE : 10.82 (-1.90%)
NERV : 3.08 (-2.61%)
ATAI : 1.3000 (-3.70%)
CYBN : 0.2649 (-0.04%)
Minerva Neurosciences: Q3 Earnings Snapshot AP - Wed Nov 9, 2022

Minerva Neurosciences: Q3 Earnings Snapshot

NERV : 3.08 (-2.61%)

Barchart Exclusives

3 Top-Rated Dividend Kings Trading Near Their 52-Week Lows Barchart - 17 minutes ago
These quality companies all have something in common: They are trading a little off their 52-week lows and pay an ever-increasing dividend. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot